Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by jopatcloon Jan 19, 2024 10:10am
59 Views
Post# 35835707

RE:RE:Interesting Dr.G.A. is a visionary for Ventripoint

RE:RE:Interesting Dr.G.A. is a visionary for Ventripointnow 0.32$ go pass 0.64$... news coming...1) conclusion of sales, 2) announcement of 4.0 finalization, 3) further Ascend update and 4) new partnership 5) conclusion of various 3rd party studies/trails. 6)Edison... Well done, Dr. Alvira and Dr. George Adams, continue your great work for our children. From Jeffrey Soble, MD, President & CEO of ASCEND: “Our aim is to provide clinicians with reliable and effective tools on a global scale.” Stay tuned for more updates on this exciting collaboration!
10:01 R 0,32  0,035 0,31 0,32 500 / 64 000 101,22k 0,32 0,3000
nice Chart
Simple Moving Avg (30) ——Simple Moving Avg (90) ——Simple Moving Avg (200) ——
<< Previous
Bullboard Posts
Next >>